Jacques-Olivier Bay, Romain Guièze, Aurélie Ravinet, Richard Lemal, Aliénor Xhaard, Sébastien Bailly, Cécile Moluçon-Chabrot, Eric Hermet, Julian Biau, Pierre Verrelle, Régis Peffault de Latour, Olivier Tournilhac
CHU Clermont-Ferrand, service d'hématologie clinique adulte et de thérapie cellulaire, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 01, France. jobay@chu-clermontferrand.fr
Bulletin du cancer 2013 JunHematology Oncology has a rich history including few crucial therapeutic innovations. These were possible because of the evolution of the cell and molecular biology allowing a better understanding of basic mechanisms of cancerogenesis. We propose here to summarize the most important therapeutic innovations since the beginning of Hematology/Oncology history. We also describe evolution of therapeutic strategies themselves. New insights and therapeutic perspectives for next future are also discussed.
Jacques-Olivier Bay, Romain Guièze, Aurélie Ravinet, Richard Lemal, Aliénor Xhaard, Sébastien Bailly, Cécile Moluçon-Chabrot, Eric Hermet, Julian Biau, Pierre Verrelle, Régis Peffault de Latour, Olivier Tournilhac. Major therapeutic advances and new perspectives in onco-hematology]. Bulletin du cancer. 2013 Jun;100(6):587-99
PMID: 23735575
View Full Text